2003 - Fellow of the American Association for the Advancement of Science (AAAS)
His Virus research also covers Herpes simplex virus, Viral replication, Neutralization and Vero cell studies. Joseph C. Glorioso performs multidisciplinary study on Viral replication and Virus in his works. His research combines Virology and Vero cell. Virology is often connected to Herpes simplex virus in his work. Neutralization and Monoclonal antibody are inextricably linked to his Antibody research. Joseph C. Glorioso integrates Monoclonal antibody and Antibody in his studies. Joseph C. Glorioso performs integrative Gene and In vivo research in his work. He integrates several fields in his works, including In vivo and Gene. He integrates several fields in his works, including Molecular biology and EcoRI.
Virus and Cell culture are two areas of study in which Joseph C. Glorioso engages in interdisciplinary work. Cell culture and Virus are two areas of study in which he engages in interdisciplinary research. His work often combines Herpes simplex virus and DNA studies. With his scientific publications, his incorporates both DNA and Herpes simplex virus. His work often combines Gene and Plasmid studies. Joseph C. Glorioso carries out multidisciplinary research, doing studies in Virology and Viral replication. He performs integrative study on Viral replication and Virology. In his research, he performs multidisciplinary study on Genetics and Neuroscience. Neuroscience and Genetics are two areas of study in which he engages in interdisciplinary research.
Joseph C. Glorioso incorporates Virology and Molecular biology in his studies. He combines Molecular biology and Gene delivery in his research. Joseph C. Glorioso integrates many fields, such as Virus and Lytic cycle, in his works. His research ties Virology and Lytic cycle together. He combines Herpes simplex virus and Herpesviridae in his research. He undertakes multidisciplinary studies into Herpesviridae and Viral disease in his work. In his works, he performs multidisciplinary study on Viral disease and Interferon. Joseph C. Glorioso conducts interdisciplinary study in the fields of Interferon and Virotherapy through his research. His Cancer research research extends to Virotherapy, which is thematically connected.
Joseph C. Glorioso combines Virology and Viral entry in his research. His study deals with a combination of Viral entry and Virology. In his study, he carries out multidisciplinary Herpes simplex virus and Oncolytic virus research. Joseph C. Glorioso integrates many fields in his works, including Oncolytic virus and Herpes simplex virus. In his works, he performs multidisciplinary study on Immunology and Antigen. While working on this project, he studies both Antigen and Virus. He conducts interdisciplinary study in the fields of Virus and Viral replication through his research. His study ties his expertise on Immunology together with the subject of Viral replication. In most of his Cancer research studies, his work intersects topics such as Virotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Mark A. Kay;Joseph C Glorioso;Luigi Naldini.
Nature Medicine (2001)
Occurrence of leukaemia following gene therapy of X-linked SCID.
Donald B. Kohn;Michel Sadelain;Joseph C. Glorioso.
Nature Reviews Cancer (2003)
Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer
G Bandara;G M Mueller;J Galea-Lauri;M H Tindal.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.
Sylvie Laquerre;Rafaela Argnani;Dina B. Anderson;Silvia Zucchini.
Journal of Virology (1998)
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
S L Highlander;S L Sutherland;P J Gage;D C Johnson.
Journal of Virology (1987)
The Liver X Receptor Ligand T0901317 Decreases Amyloid β Production in Vitro and in a Mouse Model of Alzheimer's Disease
Radosveta P. Koldamova;Iliya M. Lefterov;Matthias Staufenbiel;Darren Wolfe.
Journal of Biological Chemistry (2005)
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.
D. M. Krisky;D. Wolfe;W. F. Goins;P. C. Marconi.
Gene Therapy (1998)
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus
Steven P. Wilson;David C. Yeomans;Mary Ann Bender;Ying Lu.
Proceedings of the National Academy of Sciences of the United States of America (1999)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.
Jianfeng Han;Jianhong Chu;Wing Keung Chan;Jianying Zhang.
Scientific Reports (2015)
Development and application of herpes simplex virus vectors for human gene therapy
J C Glorioso;N A DeLuca;D J Fink.
Annual Review of Microbiology (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: